We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
4 hedge funds and large institutions have $38.7K invested in ZyVersa Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.08% more ownership
Funds ownership: 0.15% → 1.23% (+1.1%)
43% less funds holding
Funds holding: 7 → 4 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
54% less capital invested
Capital invested by funds: $84.9K → $38.7K (-$46.1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$51.5K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$38 |
| 3 |
JP Morgan Chase
New York
|
+$5 |
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
-$23.4K |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$22K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14.9K |
| 4 |
Jane Street
New York
|
-$9.09K |
| 5 |
HF
HRT Financial
New York
|
-$9K |